Optimizing Bronchopulmonary Cancer Screening

Record History

See every version on ClinicalTrials.gov ↗

1. Minor Sep 9, 2026 Study sites: 8 to 9v6
2. Notable May 29, 2026 Primary completion date: Jan 17, 2032 to Feb 5, 2033

   • Study completion date: Jan 17, 2033 to Feb 5, 2034
   • Start date: Jan 17, 2025 to Jan 27, 2025
   • Site details revised at 3 of 8 sites

   v5
3. Notable Jan 30, 2025 Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less

   • Primary completion date: Dec 30, 2031 to Jan 17, 2032
   • Study completion date: Dec 30, 2032 to Jan 17, 2033
   • Start date changed from estimate of Dec 30, 2024 to Jan 17, 2025
   • Site details revised at 8 of 8 sites
4. Notable Nov 4, 2024 Start date: Oct 30, 2024 to Dec 30, 2024

   • Primary completion date: Oct 30, 2031 to Dec 30, 2031
   • Study completion date: Oct 30, 2032 to Dec 30, 2032

   v3
5. Notable Jul 23, 2024 Start date: Jun 30, 2024 to Oct 30, 2024v2 Show 8 more changesShow less

   • Study sites: 0 to 8
   • Primary completion date: Jun 30, 2031 to Oct 30, 2031
   • Study completion date: Jun 30, 2032 to Oct 30, 2032
   • Interventions: Chest CT scan and follow-up (Other), Inclusion (Other), Screening (Other) to Chest CTscan and follow-up (Other), Inclusion (Other), Screening (Other)
   • Secondary endpoints revised (10)
   • Primary endpoint revised
   • Eligibility criteria shortened, about 1 word
   • Study description expanded, about 1 word
6. Minor May 28, 2024 Study First Submitted

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.